Colin P. N. Dinney, MD, presented “Open vs Robotic Cystectomy for Bladder Cancer” during the 42nd Annual Ralph E. Hopkins Urology Seminar on February 3, 2023, in Jackson Hole, Wyoming.
How to cite: Dinney, Colin P. N. “Open vs Robotic Cystectomy for Bladder Cancer.” February 3, 2023. Accessed Nov 2024. https://grandroundsinurology.com/open-vs-robotic-cystectomy-for-bladder-cancer/
Open vs Robotic Cystectomy for Bladder Cancer – Summary
Dr. Colin P.N. Dinney outlines the fundamental differences between OC and RC, emphasizing the evolution of surgical techniques and the increasing adoption of robotic-assisted procedures. He discusses the procedural intricacies, including patient positioning, incision sites, and the technical challenges unique to each approach.
Dr. Dinney presents data on perioperative metrics such as blood loss, operative time, and complication rates, comparing the benefits and drawbacks of the two approaches. In addition, oncologic outcomes, including margin status, lymph node yield, and long-term survival rates, are compared.
About The 42nd Annual Ralph E. Hopkins Urology Seminar:
The Ralph E. Hopkins Urology Seminar is a multi-day meeting focused on training urologists in the latest in assessing, diagnosing, and treating urologic conditions in the clinical setting. Updates are provided on urologic cancers, stone disease, urologic reconstruction, female urology, infertility, sexual function, emerging surgical techniques, and general urology. The 42nd iteration of the meeting took place from February 1st to 4th, 2023, in Jackson Hole, Wyoming.
For further educational activities from this conference, visit our collection page.
ABOUT THE AUTHOR
Colin P. N. Dinney, MD, is Chairman of the Department of Urology, Division of Surgery, and also co-chairs the Genitourinary Steering Committee for the Bladder Task Force at the University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Dinney earned his MD from the University of Winnipeg, Canada and completed his residency in urology at Dalhousie University in Halifax, before moving to Houston to begin his work with the MD Anderson Cancer Center. He has published over twenty peer-reviewed articles and currently serves as a professor in the Department of Cancer Biology at the University of Texas. He is recognized as one of Houston’s top urologists and has been awarded numerous honors, such as the 2015 Society of Urologic Oncology Medal. His other appointments include serving as Co-Chair of the Orthopedic Oncology Chair Search Committee, as well as past-director of the Bladder Organ Site Committee of the Society of Urologic Oncology Clinical Trials Consortium.
